Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
American Journal of Hospital Pharmacy
|
May 1, 1973
Effect of vehicle on the stability of sodium aminosalicylate in liquid dosage forms
M I Blake, K A Makris, J Tio
Der Pathologe
|
February 3, 2009
[Immunohistochemistry in breast pathology: differential diagnosis of epithelial breast lesions]
W Böcker, D Hungermann, S Weigel, et al.
Der Pathologe
|
January 24, 2009
[Flat epithelial atypia]
W Böcker, D Hungermann, J Tio, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
April 17, 2015
Rates of presurgical underestimation of breast cancer after standardized assessment of breast calcifications
L Timpe, S Berkemeyer, M Puesken, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
April 21, 2011
Minimal invasive biopsy results of "uncertain malignant potential" in digital mammography screening: high prevalence but also high predictive value for malignancy
S Weigel, T Decker, E Korsching, et al.
British Journal of Cancer
|
April 21, 2005
Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ
P Wülfing, C Kersting, H Buerger, et al.
British Journal of Cancer
|
July 1, 2004
Expression of endothelin-A-receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer
P Wülfing, J Tio, C Kersting, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 27, 2021
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [<sup>68</sup>Ga]Ga-OncoFAP-DOTAGA
P Backhaus, F Gierse, M C Burg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 6, 2025
Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A pooled analysis of three WSG trials
M Graeser, O Gluz, C Zu Eulenburg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†
G von Minckwitz, S Loibl, M Untch, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
American Journal of Hospital Pharmacy
|
May 1, 1973
Effect of vehicle on the stability of sodium aminosalicylate in liquid dosage forms
M I Blake, K A Makris, J Tio
Der Pathologe
|
February 3, 2009
[Immunohistochemistry in breast pathology: differential diagnosis of epithelial breast lesions]
W Böcker, D Hungermann, S Weigel, et al.
Der Pathologe
|
January 24, 2009
[Flat epithelial atypia]
W Böcker, D Hungermann, J Tio, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
April 17, 2015
Rates of presurgical underestimation of breast cancer after standardized assessment of breast calcifications
L Timpe, S Berkemeyer, M Puesken, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
April 21, 2011
Minimal invasive biopsy results of "uncertain malignant potential" in digital mammography screening: high prevalence but also high predictive value for malignancy
S Weigel, T Decker, E Korsching, et al.
British Journal of Cancer
|
April 21, 2005
Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ
P Wülfing, C Kersting, H Buerger, et al.
British Journal of Cancer
|
July 1, 2004
Expression of endothelin-A-receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer
P Wülfing, J Tio, C Kersting, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 27, 2021
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [<sup>68</sup>Ga]Ga-OncoFAP-DOTAGA
P Backhaus, F Gierse, M C Burg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 6, 2025
Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A pooled analysis of three WSG trials
M Graeser, O Gluz, C Zu Eulenburg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†
G von Minckwitz, S Loibl, M Untch, et al.
Page
of 1